Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

OCTREOTIDE FOR INJECTABLE SUSPENSION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is OCTREOTIDE FOR INJECTABLE SUSPENSION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG has been permanently discontinued (last updated May 6, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is OCTREOTIDE FOR INJECTABLE SUSPENSION not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength30MG
Last updated2026-05-06

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

SANDOSTATIN LAR

NOVARTIS PHARMACEUTICALS CANADA INC

30MG · DIN 02239325

Same strengthDifferent dosage formSame routeNo current shortage

OCTREOTIDE DEPOT

STERIMAX INC

10MG · DIN 02567776

Different strengthDifferent dosage formSame routeNo current shortage

SANDOSTATIN

NOVARTIS PHARMACEUTICALS CANADA INC

500MCG · DIN 00839213

Different strengthDifferent dosage formDifferent routeNo current shortage

OCTREOTIDE ACETATE INJECTION - 500MCG/ML

SANDOZ CANADA INCORPORATED

500MCG · DIN 02263203

Different strengthDifferent dosage formDifferent routeNo current shortage

OCTREOTIDE ACETATE INJECTION - 50MCG/ML

SANDOZ CANADA INCORPORATED

50MCG · DIN 02263165

Different strengthDifferent dosage formDifferent routeNo current shortage

OCTREOTIDE ACETATE INJECTION - 100MCG/ML

SANDOZ CANADA INCORPORATED

100MCG · DIN 02263173

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

DIN

02503786

Strength

30MG

Dosage Form

POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT

Route

INTRAMUSCULAR

Active Ingredient

OCTREOTIDE

See all OCTREOTIDE products →

Shortage History